SCHEMBL29664147

SCHEMBL29664147

COc1ccc(-n2cc(Nc3ccccc3)cn2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.52
FGFR1 P11362 4/20 0.52
KDR P35968 4/20 0.52
ABCB11 O95342 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
MAPT P10636 3/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GAA P10253 2/20 0.46
THRB P10828 1/20 0.46
MAPK1 P28482 1/20 0.46
RECQL P46063 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29664327 0.84 GAA (0.53) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL29664346 0.83 HPGD (0.53) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL29664287 0.80 DRD2 (0.46) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL29664519 0.78 GAA (0.43) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL15149138 0.77 AURKA (0.50) EGFRKDRABCB11HDAC6MEN1
SCHEMBL16023810 0.75 AURKA (0.48) EGFRFGFR1KDRABCB11HDAC6
SCHEMBL16013030 0.75 RPS6KA3 (0.54) EGFRMEN1KMT2AALDH1A1CYP1A2
SCHEMBL15152315 0.75 RAB9A (0.50) KDRMEN1KMT2ARAB9ANPC1
SCHEMBL316390 0.75 RAB9A (0.81) EGFRMEN1KMT2ARAB9ANPC1
SCHEMBL9479393 0.75 RAB9A (0.81) EGFRMEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728909-A Composition for preventing or treating cancer comprising novel trifluoromethylphenylpyrazole derivative as active ingredient 韩国原子力医学院 2022-07-08 CN disclosed